Geneos Wealth Management’s Nuveen ESG Large-Cap Value ETF NULV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-272
Closed -$11.9K 2523
2025
Q3
$11.9K Buy
+272
New +$11.6K ﹤0.01% 1905
2025
Q1
Sell
-224
Closed -$8.82K 3123
2024
Q4
$8.82K Hold
224
﹤0.01% 2099
2024
Q3
$9.35K Sell
224
-51
-19% -$2.02K ﹤0.01% 1861
2024
Q2
$10.4K Hold
275
﹤0.01% 1540
2024
Q1
$10.7K Sell
275
-172
-38% -$6.32K ﹤0.01% 1533
2023
Q4
$16.1K Sell
447
-148
-25% -$5.06K ﹤0.01% 1429
2023
Q3
$20K Sell
595
-56
-9% -$1.96K ﹤0.01% 1369
2023
Q2
$22.6K Hold
651
﹤0.01% 1331
2023
Q1
$22.2K Hold
651
﹤0.01% 1312
2022
Q4
$22.3K Hold
651
﹤0.01% 1304
2022
Q3
$20K Hold
651
﹤0.01% 1327
2022
Q2
$21K Hold
651
﹤0.01% 1666
2022
Q1
$24K Hold
651
﹤0.01% 1718
2021
Q4
$25K Hold
651
﹤0.01% 1772
2021
Q3
$24K Hold
651
﹤0.01% 1825
2021
Q2
$24K Sell
651
-38
-6% -$1.43K ﹤0.01% 1819
2021
Q1
$25K Sell
689
-1,374
-67% -$47.1K ﹤0.01% 1959
2020
Q4
$73K Buy
+2,063
New +$64.6K ﹤0.01% 1271

Other funds holding NULV

Geneos Wealth Management's NULV Position: Q4 2025 in Review

Geneos Wealth Management sold out of Nuveen ESG Large-Cap Value ETF (NULV) in Q4 2025, closing a stake of 272 shares — an estimated $11.9K sold.

Geneos Wealth Management first reported a position in NULV in Q4 2020 and held it in 18 quarters. The position peaked at $73K in Q4 2020. 275 funds tracked by Wall St. Rank hold NULV as of Q4 2025.

  • Geneos Wealth Management reported no remaining Nuveen ESG Large-Cap Value ETF position as of Q4 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 272 Nuveen ESG Large-Cap Value ETF shares in Q4 2025, an estimated $11.9K.
  • Geneos Wealth Management first reported a position in Nuveen ESG Large-Cap Value ETF in Q4 2020 and held it in 18 quarters.
  • Geneos Wealth Management's Nuveen ESG Large-Cap Value ETF position peaked at $73K in Q4 2020.
  • 275 funds tracked by Wall St. Rank held Nuveen ESG Large-Cap Value ETF as of Q4 2025.

Based on Geneos Wealth Management's 13F filing for Q4 2025, filed 28 Jan 2026.